Citigroup’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,586,334
Closed -$108M 5380
2022
Q3
$108M Buy
1,586,334
+1,397,250
+739% +$95.2M 0.08% 148
2022
Q2
$6.04M Buy
189,084
+143,381
+314% +$4.58M ﹤0.01% 1040
2022
Q1
$1.58M Sell
45,703
-121,425
-73% -$4.21M ﹤0.01% 1957
2021
Q4
$4.89M Buy
167,128
+76,303
+84% +$2.23M ﹤0.01% 1300
2021
Q3
$2.31M Sell
90,825
-23,762
-21% -$605K ﹤0.01% 1807
2021
Q2
$4.01M Buy
114,587
+15,418
+16% +$540K ﹤0.01% 1599
2021
Q1
$4.04M Buy
99,169
+85,594
+631% +$3.49M ﹤0.01% 1471
2020
Q4
$588K Buy
13,575
+4,422
+48% +$192K ﹤0.01% 2529
2020
Q3
$505K Sell
9,153
-39,424
-81% -$2.18M ﹤0.01% 2242
2020
Q2
$3.07M Buy
48,577
+2,446
+5% +$154K ﹤0.01% 1332
2020
Q1
$2.36M Buy
46,131
+1,783
+4% +$91.1K ﹤0.01% 1305
2019
Q4
$3.53M Buy
44,348
+6,895
+18% +$548K ﹤0.01% 1299
2019
Q3
$1.82M Buy
37,453
+11,601
+45% +$563K ﹤0.01% 1692
2019
Q2
$1.36M Buy
25,852
+14,299
+124% +$752K ﹤0.01% 1910
2019
Q1
$612K Sell
11,553
-211,582
-95% -$11.2M ﹤0.01% 2345
2018
Q4
$9.16M Buy
223,135
+187,762
+531% +$7.71M 0.01% 742
2018
Q3
$1.35M Sell
35,373
-8,071
-19% -$307K ﹤0.01% 1771
2018
Q2
$1.96M Buy
43,444
+13,639
+46% +$617K ﹤0.01% 1485
2018
Q1
$1.44M Sell
29,805
-36,366
-55% -$1.76M ﹤0.01% 1613
2017
Q4
$2.6M Buy
66,171
+12,014
+22% +$473K ﹤0.01% 1323
2017
Q3
$1.68M Sell
54,157
-33,662
-38% -$1.05M ﹤0.01% 1604
2017
Q2
$2.4M Buy
87,819
+75,980
+642% +$2.08M ﹤0.01% 1368
2017
Q1
$436K Sell
11,839
-487
-4% -$17.9K ﹤0.01% 2494
2016
Q4
$179K Buy
12,326
+10,684
+651% +$155K ﹤0.01% 3624
2016
Q3
$37K Buy
1,642
+92
+6% +$2.07K ﹤0.01% 3890
2016
Q2
$26K Sell
1,550
-4,104
-73% -$68.8K ﹤0.01% 4065
2016
Q1
$90K Buy
5,654
+3,541
+168% +$56.4K ﹤0.01% 3991
2015
Q4
$68K Buy
2,113
+2,111
+105,550% +$67.9K ﹤0.01% 3854
2015
Q3
$0 Buy
+2
New ﹤0.01% 5661